0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
JAMA Patient Page |

Bladder Cancer FREE

Janet M. Torpy, MD, Writer; Cassio Lynm, MA, Illustrator; Richard M. Glass, MD, Editor
JAMA. 2005;293(7):890. doi:10.1001/jama.293.7.890.
Text Size: A A A
Published online

Urine is formed by the kidney and stored in the bladder. The bladder expands and contracts depending on how much urine is stored inside. Cancer can develop in the bladder as it does in other bodily organs. Most bladder cancer arises in the cells that line the bladder. The February 16, 2005, issue of JAMA includes an article about bladder cancer.

SYMPTOMS OF BLADDER CANCER

  • Blood in the urine

  • Frequent urination

  • Painful urination

RISK FACTORS FOR BLADDER CANCER

  • Smoking greatly increases the chance of having bladder cancer. Smoking also increases the death rate from bladder cancer.

  • Older persons have a greater risk for bladder cancer than younger individuals.

  • Men develop bladder cancer 4 times more often than women.

DIAGNOSIS

Diagnosis and treatment of bladder cancer is usually done by a urologist (a doctor with specialized training in surgery of the urinary tract). Urine may be sent to the lab for analysis, cell count, or culture. Cystoscopy, passing a lighted tube into the bladder through the urethra (the tube that carries urine from the bladder to outside the body), may be performed to see the inner lining of the bladder and examine it for growths or tumors. Biopsies (small samples of tissue) may be taken to examine under a microscope. Other testing may include an intravenous pyelogram, an x-ray test using dye to look at the kidneys and ureters, the tubes that drain urine into the bladder from the kidneys. If more invasive bladder cancer is suspected, other tests may be done to determine if the cancer has spread to other areas.

TREATMENT

Treatment usually includes transurethral (through the urethra) resection of the bladder tumor. This surgical procedure is done with the patient under anesthesia. More extensive surgery may be needed if the bladder tumor has invaded beyond the lining of the bladder. This may include cystectomy (removal of the bladder) with creation of a urine-draining system. Chemotherapy (use of anticancer medications), radiation (x-ray) therapy, and immunologic therapy may be used to treat advanced bladder cancer. Immunologic therapy uses biologic agents to help the body's own immune system fight the bladder cancer. Cancer clinical trials are an option for individuals who have advanced or recurrent bladder cancer that has been resistant to standard treatment.

FOR MORE INFORMATION

INFORM YOURSELF

To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com. A Patient Page on cancer clinical trials was published in the June 9, 2004, issue; and one on kidney cancer was published in the July 7, 2004, issue.

Sources: American Cancer Society, National Cancer Institute, American Foundation for Urologic Disease

The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. Any other print or online reproduction is subject to AMA approval. To purchase bulk reprints, call 718/946-7424.

TOPIC: CANCER

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles